190 related articles for article (PubMed ID: 11380451)
21. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
Loirat C; Veyradier A; Girma JP; Ribba AS; Meyer D
Semin Thromb Hemost; 2006 Mar; 32(2):90-7. PubMed ID: 16575683
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
[TBL] [Abstract][Full Text] [Related]
25. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Tsai HM
J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
[TBL] [Abstract][Full Text] [Related]
26. ADAMTS13 and TTP.
Zheng X; Majerus EM; Sadler JE
Curr Opin Hematol; 2002 Sep; 9(5):389-94. PubMed ID: 12172456
[TBL] [Abstract][Full Text] [Related]
27. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
28. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.
Kinoshita S; Yoshioka A; Park YD; Ishizashi H; Konno M; Funato M; Matsui T; Titani K; Yagi H; Matsumoto M; Fujimura Y
Int J Hematol; 2001 Jul; 74(1):101-8. PubMed ID: 11530798
[TBL] [Abstract][Full Text] [Related]
29. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM
Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921
[TBL] [Abstract][Full Text] [Related]
31. Thrombocytopenia and severe hyperbilirubinemia in the neonatal period secondary to congenital thrombotic thrombocytopenic purpura and ADAMTS13 deficiency.
Schiff DE; Roberts WD; Willert J; Tsai HM
J Pediatr Hematol Oncol; 2004 Aug; 26(8):535-8. PubMed ID: 15284596
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
[TBL] [Abstract][Full Text] [Related]
33. Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.
Rock G; Anderson D; Clark W; Leblond P; Palmer D; Sternbach M; Sutton D; Wells G; ;
Br J Haematol; 2005 Apr; 129(1):79-86. PubMed ID: 15801959
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
35. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
36. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
[TBL] [Abstract][Full Text] [Related]
37. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
Yarranton H; Lawrie AS; Purdy G; Mackie IJ; Machin SJ
Transfus Med; 2004 Feb; 14(1):39-44. PubMed ID: 15043592
[TBL] [Abstract][Full Text] [Related]
38. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.
Savasan S; Lee SK; Ginsburg D; Tsai HM
Blood; 2003 Jun; 101(11):4449-51. PubMed ID: 12576319
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Prevention of Congenital Thrombotic Thrombocytopenic Purpura in ADAMTS13 Knockout Mice by Sleeping Beauty Transposon-Mediated Gene Therapy.
Verhenne S; Vandeputte N; Pareyn I; Izsvák Z; Rottensteiner H; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):836-844. PubMed ID: 28254814
[TBL] [Abstract][Full Text] [Related]
40. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura.
Sahud MA; Claster S; Liu L; Ero M; Harris K; Furlan M
Br J Haematol; 2002 Mar; 116(4):909-11. PubMed ID: 11886400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
